A detailed history of Skopos Labs, Inc. transactions in Metlife Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 10,854 shares of MET stock, worth $853,558. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,854
Previous 21,609 49.77%
Holding current value
$853,558
Previous $1.78 Million 49.75%
% of portfolio
0.11%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$73.82 - $82.37 $793,934 - $885,889
-10,755 Reduced 49.77%
10,854 $894,000
Q3 2025

Nov 14, 2025

BUY
$73.82 - $82.37 $766,915 - $855,741
10,389 Added 92.59%
21,609 $1.78 Million
Q2 2025

Aug 14, 2025

BUY
$68.42 - $82.49 $337,926 - $407,418
4,939 Added 78.63%
11,220 $902,000
Q1 2025

May 13, 2025

BUY
$77.7 - $87.0 $255,788 - $286,404
3,292 Added 110.14%
6,281 $504,000
Q4 2024

Jan 15, 2025

BUY
$78.15 - $88.25 $28,055 - $31,681
359 Added 13.65%
2,989 $244,000
Q3 2024

Nov 13, 2024

BUY
$67.96 - $82.48 $178,734 - $216,922
2,630 New
2,630 $216,000

Others Institutions Holding MET

About METLIFE INC


  • Ticker MET
  • Exchange NYSE
  • Sector Financial Services
  • Industry Insurance—Life
  • Shares Outstandng 797,614,016
  • Market Cap $62.7B
  • Description
  • MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...
More about MET
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.